Sutro Biopharma, Inc.

STRO

$20.54

+0.34%

N/A+$0.07

Healthcare

Biotechnology

NASDAQ

Active Trading

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective ...

Supply Chain of STRO

Upstream / Downstream / Proxies

Upstream

Boehringer Ingelheim BioXcellenceVGXI, Inc. (subsidiary of GeneOne Life Science)KOSDAQ:011000The Scripps Research InstituteThird-party CROs and CMOs (various unnamed)GeneOne Life Science, Inc.KOSDAQ:011000

Downstream

Ipsen S.A.EURONEXT:IPNAstellas Pharma Inc.TSE:4503Merck KGaA (Darmstadt, Germany)XETRA:MRKBristol Myers Squibb CompanyNYSE:BMYTasly Pharmaceutical Group Co., Ltd.SHA:600535Vaxcyte, Inc.NASDAQ:PCVX

Proxies

Mersana Therapeutics, Inc.NASDAQ:MRSN ADC Therapeutics SANYSE:ADCT Zymeworks Inc.NASDAQ:ZYMEImmunoGen, Inc. (now AbbVie)Unconfirmed

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer